SynopsisEculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The global Soliris Drug market size is expected to reach US$ 1746.8 million by 2029, gro.....
SynopsisDrugs used as treatments for asthma and COPD The global Drugs for Asthma and COPD market size is expected to reach US$ 68020 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drug.....
SynopsisMedical imaging informatics, also referred as imaging informatics and radiology informatics, are used to exchange and transfer medical images throughout the healthcare systems. The global Medical Imaging Informatics market size is expected to reach US$ 4.....
SynopsisCefradine is a first generation cephalosporin antibiotic. The global Cephradine market size is expected to reach US$ 505.5 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Cephra.....
SynopsisA breathalyzer or breathalyser is a device for estimating blood alcohol content (BAC) from a breath sample. The global Point-of-Care Breathalyzer market size is expected to reach US$ 1213 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The .....
SynopsisAdenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. The global Adenosine Deaminase Deficiency market size is expected to reach US$ 174.1 m.....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
SynopsisTelecom operators are waging a war for connectivity and customer intimacy. The global Telecom Consulting market size is expected to reach US$ 12110 million by 2029, growing at a CAGR of 11.8% from 2023 to 2029. The market is mainly driven by the signifi.....
SynopsisENT Devices used for diagnostic The global Diagnostic ENT Devices market size is expected to reach US$ 2177.1 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Diagnostic ENT Devi.....
SynopsisHepatitis C drugs are medications used to treat hepatitis C virus (HCV) infection. Over the years, significant advancements have been made in HCV treatment, leading to the development of direct-acting antivirals (DAAs). These drugs target specific steps in the.....
